{
    "2019-02-12": [
        [
            {
                "time": "2023-10-01",
                "original_text": "AbbVie Buys Rights to Novel Immunotherapy for Multiple Myeloma",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Buys",
                        "Immunotherapy",
                        "Multiple Myeloma"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Better Buy: Gilead Sciences vs. Pfizer",
                "features": {
                    "keywords": [
                        "Gilead Sciences",
                        "Pfizer",
                        "Better Buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "5 Aristocrats for Stable Income",
                "features": {
                    "keywords": [
                        "Aristocrats",
                        "Stable Income"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dividend stocks"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "5 High-Growth Stocks Undervalued by the Market",
                "features": {
                    "keywords": [
                        "High-Growth Stocks",
                        "Undervalued",
                        "Market"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "growth stocks"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}